| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 03/09/1999 | US5879893 Hybridization method for detecting polynucleotides coding for signal transduction inhibitor protein in body fluids and tissue samples; treatment of alzheimer's disease and cancer |
| 03/09/1999 | US5879892 Relates to nucleic acid molecules and encoded polypeptides which are expressed preferentially in leukemia. |
| 03/09/1999 | US5879710 Comprising melatonin and melatonin derivatives, acrylic acid polymeric resin, magnesium stearate, lactose diluent, polyvinylpyrrolidinone and cellulose derivatives |
| 03/09/1999 | US5879687 Enhancing or eliciting cellular and/or humoral immune response, for treating tumors |
| 03/09/1999 | US5879675 Opsonizing tumor cell obtained from animal by incubating in presence of alpha-galactosyl epitope and glycosphingolipids to insert epitope into cell membrane, irradiating cell, administering to animal |
| 03/09/1999 | CA2038279C Cd25 binding molecules |
| 03/09/1999 | CA1340422C Anthracycline derivatives having cytostatic activity |
| 03/08/1999 | CA2242476A1 Novel compositions containing cyclosporin |
| 03/05/1999 | CA2212237A1 Novel antineoplastic agents |
| 03/04/1999 | WO1999010525A1 A method of treating cancer |
| 03/04/1999 | WO1999010524A1 A method of treating cancer |
| 03/04/1999 | WO1999010516A2 Methods and compositions for therapies using genes encoding secreted proteins such as interferon-beta |
| 03/04/1999 | WO1999010502A1 Human nucleotide pyrophosphohydrolase |
| 03/04/1999 | WO1999010486A2 Mdm2-specific antisense oligonucleotides |
| 03/04/1999 | WO1999010480A2 New tissue-specific calpaines, their production and their use |
| 03/04/1999 | WO1999010382A1 Peptides which elicit cytotoxic t cellular immunity |
| 03/04/1999 | WO1999010379A1 Crystal of sm3 antibody (fragment) and recognizing epitope, its preparation, encoded data storage medium containing its coordinates and its diagnostical or medical use |
| 03/04/1999 | WO1999010375A2 Vaccine against hpv |
| 03/04/1999 | WO1999010371A2 Cyclopeptide derivatives as adhesion inhibitors |
| 03/04/1999 | WO1999010364A1 Follistatin-3 |
| 03/04/1999 | WO1999010339A1 2-aminopyridines containing fused ring substituents as nos inhibitors |
| 03/04/1999 | WO1999010332A1 Prostaglandin endoperoxide h synthase biosynthesis inhibitors |
| 03/04/1999 | WO1999010325A1 Benzylidene-1,3-dihydro-indol-2-one derivatives as receptor tyrosine kinase inhibitors, particularly of raf kinases |
| 03/04/1999 | WO1999010322A1 Bi-aromatic compounds bound by a heteroethynylene radical and pharmaceutical and cosmetic compositions containing same |
| 03/04/1999 | WO1999010308A1 Biphenyl derivatives substituted by an aromatic or heteroaromatic radical and pharmaceutical and cosmetic compositions containing same |
| 03/04/1999 | WO1999010014A2 Receptor-mediated gene delivery using bacteriophage vectors |
| 03/04/1999 | WO1999009996A1 Camptothecin analogs and methods of preparation thereof |
| 03/04/1999 | WO1999009985A1 Inhibitors of prenyl-protein transferase |
| 03/04/1999 | WO1998055607A3 Tumor targeted vector |
| 03/04/1999 | WO1998043678A3 Tetraaza- or n2s2- complexants, and their use in radiodiagnostics or radiotherapy |
| 03/04/1999 | DE19737105A1 Neue gewebsspezifische Calpaine, ihre Herstellung und Verwendung New tissue-specific calpain, their preparation and use |
| 03/04/1999 | CA2302525A1 Follistatin-3 |
| 03/04/1999 | CA2302293A1 Receptor-mediated gene delivery using bacteriophage vectors |
| 03/04/1999 | CA2301880A1 A method of treating cancer |
| 03/04/1999 | CA2301857A1 A method of treating cancer |
| 03/04/1999 | CA2301840A1 Peptides which elicit cytotoxic t cellular immunity |
| 03/04/1999 | CA2301816A1 Mdm2-specific antisense oligonucleotides |
| 03/04/1999 | CA2301815A1 New tissue-specific calpaines, their production and their use |
| 03/04/1999 | CA2301770A1 Inhibitors of prenyl-protein transferase |
| 03/04/1999 | CA2301661A1 Human nucleotide pyrophosphohydrolase |
| 03/04/1999 | CA2301182A1 Cyclopeptide derivatives |
| 03/04/1999 | CA2300370A1 Crystal of sm3 antibody (fragment) and recognizing epitope, its preparation, encoded data storage medium containing its coordinates and its diagnostical or medical use |
| 03/04/1999 | CA2294548A1 Pyridazinones as prostaglandin endoperoxide h synthase biosynthesis inhibitors |
| 03/03/1999 | EP0899335A2 MurB gene from Staphylococcus aureus |
| 03/03/1999 | EP0899332A2 The G-protein coupled receptor HFIAO41 |
| 03/03/1999 | EP0899330A1 Polypeptide isolated from the epidermis and its use |
| 03/03/1999 | EP0899261A1 Optical active 1,4-dihydropyridine compounds as bradykinin antagonists |
| 03/03/1999 | EP0898968A1 Antitumor agent comprising a complex of an oxidoreductase and a polymer and a substrate of the enzyme |
| 03/03/1999 | EP0898580A1 Methods and means for inhibition of cdk4 activity |
| 03/03/1999 | EP0898562A1 Hydroxamic acid derivatives for use with the treatment of diseases related to connective tissue degradation |
| 03/03/1999 | EP0898478A1 Stimulation of host defence mechanisms against tumors |
| 03/03/1999 | EP0820462B1 Hydrolysis and photocleavage of nucleic acid using a metal complex |
| 03/03/1999 | EP0724570B1 Amidino derivatives useful as nitric oxide synthase inhibitors |
| 03/03/1999 | EP0595798B1 Bispecific heteroantibodies with dual effector functions |
| 03/03/1999 | EP0537276B1 Cancer-associated scm-recognition factor, preparation and method of use |
| 03/03/1999 | EP0500928B1 Endocurietherapy |
| 03/03/1999 | CN1209876A Isolated tyrosinase derived peptides and uses thereof |
| 03/03/1999 | CN1209754A Perfluoroalkyl-containing metal complexes, its preparing method and use in NMR diagnostics |
| 03/03/1999 | CN1209746A Method of inhibiting musculoaponeurotic fibromatoses (desmoid tumors) |
| 03/03/1999 | CN1209745A Method of inhibiting colon tumors |
| 03/03/1999 | CN1209744A Vitronectin receptor antagonists |
| 03/03/1999 | CN1209329A Granulated preparation for promoting blood-circulation and removing blood stasis |
| 03/02/1999 | US5877342 Skin disorders; respiratory system disorders; cardiovascular disorders |
| 03/02/1999 | US5877309 Nucleotide sequences which suppress expression of jun n-terminal kinase oncogene by complementary hybridization; antiproliferative agents, antitumor agents, anticarcinogenic agentsand antimetastasis agents |
| 03/02/1999 | US5877308 Synthetic oligonucleotide that is complemtary to capl mrna including the 3' splice site thereby inhibiting capl gene expression; anticarcinogenic agents |
| 03/02/1999 | US5877305 DNA encoding biosynthetic binding protein for cancer marker |
| 03/02/1999 | US5877296 Reacting disulfide analogs of calicheamicin family with a carrier such as protein, peptide, mono and polyclonal antibodies, their antigen-recognizing fragments and chemically or genetically engineered counterparts |
| 03/02/1999 | US5877293 CDR grafted anti-CEA antibodies and their production |
| 03/02/1999 | US5877289 Tissue factor compositions and ligands for the specific coagulation of vasculature |
| 03/02/1999 | US5877282 Peptide inhibitors of nuclear protein translocation having nuclear localization sequences and methods of use thereof |
| 03/02/1999 | US5877219 Non-steroidal ligands for the estrogen receptor |
| 03/02/1999 | US5877213 Compositions and methods for therapy and prevention of cancer, AIDS, and anemia |
| 03/02/1999 | US5877210 Controlling immune response |
| 03/02/1999 | US5877206 Methods for inhibiting topoisomerase using procyanidin oligomers |
| 03/02/1999 | US5877202 Indole derivatives useful to treat estrogen-related neoplasms and disorders |
| 03/02/1999 | US5877178 Aids therapy |
| 03/02/1999 | US5877177 Carboxy piperidylacetamide tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases |
| 03/02/1999 | US5877167 Method for inhibition of cell motility by sphingosine-1-phosphate and its derivatives |
| 03/02/1999 | US5877148 Treatment of cancer with human chorionic gonadotropin |
| 03/02/1999 | US5877147 Muramyl peptide for prophylaxis of cancer |
| 03/02/1999 | US5877017 Isolated nucleic acid molecule encoding peptides which form complexes with MHC molecule HLA-Cw*1601 and uses thereof |
| 03/02/1999 | US5877016 Human trk receptors and neurotrophic factor inhibitors |
| 03/02/1999 | US5877010 Thymidine kinase mutants |
| 03/02/1999 | US5876979 RNA component of mouse, rat, Chinese hamster and bovine telomerase |
| 03/02/1999 | US5876973 Method for making antibodies which specifically bind to glial growth factors |
| 03/02/1999 | US5876972 Nucleic acid molecules coding for tumor suppressor proteins and methods for their isolation |
| 03/02/1999 | US5876967 Fibroblast growth factor homologous factor-2 and methods of use |
| 03/02/1999 | US5876966 Compounds and methods for the stimulation and enhancement of protective immune responses and IL-12 production |
| 03/02/1999 | US5876965 Nucleic acid encoding ARF-19, a novel regulator of the mammalian cell cycle |
| 03/02/1999 | US5876963 Human nucleotide pyrophosphohydrolase |
| 03/02/1999 | US5876943 Antigenic polypeptide produced by genetic engineering for use in diagnosis of and vaccines to peptic ulcers and stomach cancer |
| 03/02/1999 | US5876714 Polypeptide |
| 03/02/1999 | US5876693 Hydroxyalkyl phosphine compounds for use as diagnostic and therapeutic pharmaceuticals |
| 03/02/1999 | US5876691 Screening a bacteriophage library; diagnosis of colorectal tumors |
| 03/02/1999 | CA2165419C Carbo-acyclic nucleoside derivatives as antiviral and antineoplastic agents |
| 03/02/1999 | CA1340417C Monoclonal antibodies specific to human epidermal growth factor receptor and therapeutic methods employing same |
| 02/25/1999 | WO1999009214A1 Antisense oligonucleotide compositions and methods for the modulation of jnk proteins |
| 02/25/1999 | WO1999009191A1 Vectors for treating cancer |
| 02/25/1999 | WO1999009182A2 Rab proteins |
| 02/25/1999 | WO1999009171A1 Ubc7-like ubiquitin-conjugating enzyme |